The SAFE-BioPharma Association is revolutionizing the information lifecycle in life sciences. Its efforts are supported by the Pharmaceutical Research and Manufacturers Association and major pharmaceutical companies seeking to streamline identity management. The SAFE-BioPharma Association is transforming electronic document processing by addressing the standards, legal policies, and technologies necessary to help ensure document authenticity. Life sciences companies joining the association and adopting the Secure Access for Everyone (SAFE) standards for digital signatures can reduce time to market and the cost of clinical trials.
Adobe's support for the SAFE digital signature standards allows life sciences companies to reduce costly paper-based business processes involved in developing a new drug. Using Adobe solutions, SAFE members can streamline the movement of authenticated information across lines of business, between headquarters and clinical investigators, and among companies and government regulators.
Adobe and the SAFE-BioPharma Association solution brief (PDF, 214k)
Discover how Adobe helps reduce product development cycles by automating document-based processes.
Adobe electronic forms for clinical development solution brief (PDF, 517k)
Protect documents from creation to delivery and beyond.
Read more about Adobe's commitment to industry standards, which help establish a common information sharing infrastructure for the secure and reliable distribution and exchange of electronic documents.
Adobe solutions provide persistent document security capabilities that:
Learn more about how Adobe solutions — which include Adobe PDF, Adobe Acrobat® software, and the Adobe LiveCycle™ server software — help support SAFE standards.